NFKB1 and diabetic kidney disease: In addition, the NF-κB inhibitor, BAY 11-7082 and a small molecule analog of resveratrol, have been reported to reduce renal inflammation in mouse models of DKD by inhibiting the activation of NF-κB, exerting renoprotective effects.